Phosphodiesterase Inhibitors in the Therapy of Severe Septic Shock
Authors:
E. Kasal; I. Chytra; R. Bosman; V. Štruncová
Authors‘ workplace:
ARK FN Plzeň, přednosta doc. MUDr. Eduard Kasal, CSc.
Published in:
Anest. intenziv. Med., , 2001, č. 3, s. 138-140
Category:
Overview
Phosphodiesterase inhibitors (amrinone) can be used in the therapy of heart failure in severe sepsis. Their effect is different than effect of adrenergicinotropics effect, but inotropics are used as the therapy of the first choice. Especially the combination of the both groups of drugs is very effective andcan be helpful for the circulatory stabilization of severe septic shock. In the case presentation favourable circulatory effect of amrinone is presentedin the 19 years old patient with meningococcal severe septic shock.
Key words:
sepsis - heart failure - invasive meningococcal disease - amrinone
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2001 Issue 3
Most read in this issue
- Capnometry - Benefit in Out-of-Hospital Emergency Care
- Inhalation of the Nitric Oxide (NO) in Patients with ARDS - Responders and Nonresponders
- Phosphodiesterase Inhibitors in the Therapy of Severe Septic Shock
- Echocardiography as a Part of Haemodynamic Monitoring in Intensive Care